Literature DB >> 18568648

Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.

A F M Fakhrul Islam1, Stephen W Walkden-Brown, Peter J Groves, Gregory J Underwood.   

Abstract

Two experiments in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) and challenged with Marek's disease virus (MDV) investigated the effects of the vaccination-to-challenge interval (VCI) on vaccinal protection against Marek's disease, and the kinetics of MDV and HVT load in the spleen and feather dander determined using real-time quantitative polymerase chain reaction. Experiment 1 in isolators tested VCI of 2, 4 and 7 days, while Experiment 2 in floor pens tested VCI of 0, 2, 4, 7 and 10 days. MDV challenge induced gross Marek's disease lesions in 14% to 74% of chickens by 56 days post-challenge. Vaccinal protection increased from approximately 40% to approximately 80% with increasing VCI between days 2 and 7 in both experiments, but not thereafter. MDV was detected in both the spleen and dander at 7 days post-challenge and increased rapidly to approximately 21 days post-challenge, after which levels plateaued, rose or fell gradually depending on treatment. HVT was also shed in significant amounts, 1 to 2 logs lower than for MDV, with a clear peak around 14 to 21 days post-vaccination. Vaccination significantly reduced the log(10)MDV load in the spleen (vaccinated, 2.99+/-0.20/10(6) spleen cells; unvaccinated, 4.60+/-0.23/10(6) spleen cells) and dander (vaccinated, 5.28+/-0.13/mg; unvaccinated, 6.00+/-0.18/mg) from infected chickens. The MDV load had a significant negative association with the VCI and the level of vaccinal protection. Measurement of dander production in Experiment 1 and the dust content of air in Experiment 2, combined with determination of the MDV load in these, enabled estimation of total daily shedding rates of MDV per chicken and of the MDV load in air for the first time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568648     DOI: 10.1080/03079450701802230

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  10 in total

1.  Rapid, Sensitive, and Species-Specific Detection of Conventional and Recombinant Herpesvirus of Turkeys Vaccines Using Loop-Mediated Isothermal Amplification Coupled With a Lateral Flow Device Readout.

Authors:  Giulia Mescolini; Susan J Baigent; Elena Catelli; Venugopal K Nair
Journal:  Front Vet Sci       Date:  2022-06-23

2.  Marek's disease virus late protein expression in feather follicle epithelial cells as early as 8 days postinfection.

Authors:  Keith W Jarosinski
Journal:  Avian Dis       Date:  2012-12       Impact factor: 1.577

3.  Industry-Wide Surveillance of Marek's Disease Virus on Commercial Poultry Farms.

Authors:  David A Kennedy; Christopher Cairns; Matthew J Jones; Andrew S Bell; Rahel M Salathé; Susan J Baigent; Venugopal K Nair; Patricia A Dunn; Andrew F Read
Journal:  Avian Dis       Date:  2017-06       Impact factor: 1.577

4.  Modelling Marek's disease virus (MDV) infection: parameter estimates for mortality rate and infectiousness.

Authors:  Katherine E Atkins; Andrew F Read; Nicholas J Savill; Katrin G Renz; Stephen W Walkden-Brown; Mark E J Woolhouse
Journal:  BMC Vet Res       Date:  2011-11-11       Impact factor: 2.741

5.  DNA from Dust: Comparative Genomics of Large DNA Viruses in Field Surveillance Samples.

Authors:  Utsav Pandey; Andrew S Bell; Daniel W Renner; David A Kennedy; Jacob T Shreve; Chris L Cairns; Matthew J Jones; Patricia A Dunn; Andrew F Read; Moriah L Szpara
Journal:  mSphere       Date:  2016-10-05       Impact factor: 4.389

Review 6.  Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells.

Authors:  Angita Shrestha; Jean-Remy Sadeyen; Munir Iqbal
Journal:  Vaccines (Basel)       Date:  2018-11-15

7.  Evaluation of Recombinant Herpesvirus of Turkey Laryngotracheitis (rHVT-LT) Vaccine against Genotype VI Canadian Wild-Type Infectious Laryngotracheitis Virus (ILTV) Infection.

Authors:  Catalina Barboza-Solis; Shahnas M Najimudeen; Ana Perez-Contreras; Ahmed Ali; Tomy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Frank van der Meer; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2021-12-03

8.  Pathogenicity and vaccine efficacy of two virulent infectious laryngotracheitis virus strains in Egypt.

Authors:  Mohamed El-Saied; Magdy M El-Mahdy; Mahmoud Bayoumi; Reem A Soliman; Marwa F Elsayed; Ezz El-Din Sakr; Mostafa Bastami; Munir M El-Safty; Mohamed Shaalan
Journal:  BMC Vet Res       Date:  2022-09-26       Impact factor: 2.792

9.  Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens.

Authors:  Andrew F Read; Susan J Baigent; Claire Powers; Lydia B Kgosana; Luke Blackwell; Lorraine P Smith; David A Kennedy; Stephen W Walkden-Brown; Venugopal K Nair
Journal:  PLoS Biol       Date:  2015-07-27       Impact factor: 8.029

Review 10.  A Review of Pathogen Transmission at the Backyard Chicken-Wild Bird Interface.

Authors:  Andrea J Ayala; Michael J Yabsley; Sonia M Hernandez
Journal:  Front Vet Sci       Date:  2020-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.